These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 1465741

  • 1. Dopaminergic regulation of cortical acetylcholine release.
    Day J, Fibiger HC.
    Synapse; 1992 Dec; 12(4):281-6. PubMed ID: 1465741
    [Abstract] [Full Text] [Related]

  • 2. Dopaminergic regulation of striatal acetylcholine release: importance of D1 and N-methyl-D-aspartate receptors.
    Damsma G, Robertson GS, Tham CS, Fibiger HC.
    J Pharmacol Exp Ther; 1991 Dec; 259(3):1064-72. PubMed ID: 1837058
    [Abstract] [Full Text] [Related]

  • 3. Physiological release of striatal acetylcholine in vivo: modulation by D1 and D2 dopamine receptor subtypes.
    DeBoer P, Abercrombie ED.
    J Pharmacol Exp Ther; 1996 May; 277(2):775-83. PubMed ID: 8627558
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effects of neonatal ventral hippocampal lesion in rats on stress-induced acetylcholine release in the prefrontal cortex.
    Laplante F, Stevenson CW, Gratton A, Srivastava LK, Quirion R.
    J Neurochem; 2004 Dec; 91(6):1473-82. PubMed ID: 15584923
    [Abstract] [Full Text] [Related]

  • 7. Dopaminergic regulation of septohippocampal cholinergic neurons.
    Day JC, Fibiger HC.
    J Neurochem; 1994 Dec; 63(6):2086-92. PubMed ID: 7964727
    [Abstract] [Full Text] [Related]

  • 8. S 18126 ([2-[4-(2,3-dihydrobenzo[1,4]dioxin-6-yl)piperazin-1-yl methyl]indan-2-yl]), a potent, selective and competitive antagonist at dopamine D4 receptors: an in vitro and in vivo comparison with L 745,870 (3-(4-[4-chlorophenyl]piperazin-1-yl)methyl-1H-pyrrolo[2, 3b]pyridine) and raclopride.
    Millan MJ, Newman-Tancredi A, Brocco M, Gobert A, Lejeune F, Audinot V, Rivet JM, Schreiber R, Dekeyne A, Spedding M, Nicolas JP, Peglion JL.
    J Pharmacol Exp Ther; 1998 Oct; 287(1):167-86. PubMed ID: 9765336
    [Abstract] [Full Text] [Related]

  • 9. Glutamate receptors in nucleus accumbens mediate regionally selective increases in cortical acetylcholine release.
    Zmarowski A, Sarter M, Bruno JP.
    Synapse; 2007 Mar; 61(3):115-23. PubMed ID: 17146770
    [Abstract] [Full Text] [Related]

  • 10. In vivo comparisons of the effects of quinpirole and the putative presynaptic dopaminergic agonists B-HT 920 and SND 919 on striatal dopamine and acetylcholine release.
    Robertson GS, Tham CS, Wilson C, Jakubovic A, Fibiger HC.
    J Pharmacol Exp Ther; 1993 Mar; 264(3):1344-51. PubMed ID: 8095550
    [Abstract] [Full Text] [Related]

  • 11. The neurokinin1 receptor antagonist CP-99,994 reduces catalepsy produced by the dopamine D2 receptor antagonist raclopride: correlation with extracellular acetylcholine levels in striatum.
    Anderson JJ, Randall S, Chase TN.
    J Pharmacol Exp Ther; 1995 Aug; 274(2):928-36. PubMed ID: 7636756
    [Abstract] [Full Text] [Related]

  • 12. Dopaminergic regulation of striatal acetylcholine release: the critical role of acetylcholinesterase inhibition.
    Acquas E, Fibiger HC.
    J Neurochem; 1998 Mar; 70(3):1088-93. PubMed ID: 9489729
    [Abstract] [Full Text] [Related]

  • 13. Alpha1-adrenergic, D1, and D2 receptors interactions in the prefrontal cortex: implications for the modality of action of different types of neuroleptics.
    Gioanni Y, Thierry AM, Glowinski J, Tassin JP.
    Synapse; 1998 Dec; 30(4):362-70. PubMed ID: 9826228
    [Abstract] [Full Text] [Related]

  • 14. Comparative dopamine-cholinergic mechanisms in the olfactory tubercle and the striatum: effects of metoclopramide.
    Suarez-Roca H, Lovenberg T, Cubeddu LX.
    J Pharmacol Exp Ther; 1987 Dec; 243(3):840-51. PubMed ID: 3320346
    [Abstract] [Full Text] [Related]

  • 15. Loss of D1/D2 dopamine receptor synergisms following repeated administration of D1 or D2 receptor selective antagonists: electrophysiological and behavioral studies.
    Hu XT, White FJ.
    Synapse; 1994 May; 17(1):43-61. PubMed ID: 7913772
    [Abstract] [Full Text] [Related]

  • 16. Day/night differences in D1 but not D2 DA receptor protection from EEDQ denaturation in rats treated with continuous cocaine.
    Burger LY, Martin-Iverson MT.
    Synapse; 1993 Jan; 13(1):20-9. PubMed ID: 8093985
    [Abstract] [Full Text] [Related]

  • 17. Differential modulation of dopamine D1-receptor binding and mRNA expression in the basal ganglia by the D1-receptor antagonist, SCH-23390.
    Yu J, Coirini H, Källström L, Wiesel FA, Johnson AE.
    Synapse; 1998 Sep; 30(1):38-48. PubMed ID: 9704879
    [Abstract] [Full Text] [Related]

  • 18. Attenuation of the locomotor-sensitizing effects of the D2 dopamine agonist bromocriptine by either the D1 antagonist SCH 23390 or the D2 antagonist raclopride.
    Wise RA, Carlezon WA.
    Synapse; 1994 Jul; 17(3):155-9. PubMed ID: 7974197
    [Abstract] [Full Text] [Related]

  • 19. Evidence that neuroleptics increase striatal acetylcholine release through stimulation of dopamine D1 receptors.
    Imperato A, Obinu MC, Casu MA, Mascia MS, Dazzi L, Gessa GL.
    J Pharmacol Exp Ther; 1993 Aug; 266(2):557-62. PubMed ID: 8102643
    [Abstract] [Full Text] [Related]

  • 20. D-1 and D-2 dopamine receptor blockade: interactive effects in vitro and in vivo.
    Saller CF, Salama AI.
    J Pharmacol Exp Ther; 1986 Mar; 236(3):714-20. PubMed ID: 3005552
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.